Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026

Peptide Comparison

Semax vs Dihexa

Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.

Data-derived verdict

Semax has stronger documented evidence (Russia-Approved + Anecdotal) than Dihexa (Preclinical + Anecdotal) while both occupy the nootropic class. When clinical-evidence tier is the deciding factor, Semax is the safer pick. Dihexa may still fit a specific research framing the higher-evidence option does not cover: cost, dosing convenience, jurisdictional access, or a particular off-label use case.

Generated from catalog evidence-tier data, not editorial judgment. Both compounds share at least one mechanism class and this verdict reads the catalogued evidence tier of each, not specific trial nuance.

Evidence at a glance

Semax

Russia-Approved + Anecdotal

Dihexa

Preclinical + Anecdotal

FDA-approved   Phase 3   Phase 2 / approved abroad   Anecdotal + animal   Preclinical / flagged

Side-by-side

Semax Dihexa
Class ACTH fragment analog; nootropic Angiotensin IV analog; HGF potentiator
Drug class Cognitive Cognitive
Mechanism Upregulates BDNF and NGF; modulates dopamine and serotonin systems; neuroprotective Enhances HGF/c-Met signaling; promotes synaptogenesis and dendritic spine formation
Route Intranasal / SC Oral / Transdermal
Half-life ~5-15 min (intranasal peak) ~10 hrs
Dosage (research) 200 mcg intranasal daily (0.1% solution, 2-3 drops per nostril, nootropic starting dose, max 600 mcg/day per Russian clinical literature for stroke and cognitive support) 8-45 mg oral daily (anecdotal)
Evidence tier Russia-Approved + Anecdotal Preclinical + Anecdotal
Research depth 150 indexed (PubMed 141 · CT 0 · EPMC 9) 17 indexed (PubMed 11 · CT 0 · EPMC 6)
Availability Research / Intl Rx Research Chemical
Reported risks Mild irritability; insomnia; nasal irritation with intranasal use Very limited human data; theoretical tumor risk via HGF pathway

Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.

Frequently asked questions

Should I pick Semax or Dihexa?

Semax has stronger documented evidence (Russia-Approved + Anecdotal) than Dihexa (Preclinical + Anecdotal) while both occupy the nootropic class. When clinical-evidence tier is the deciding factor, Semax is the safer pick. Dihexa may still fit a specific research framing the higher-evidence option does not cover: cost, dosing convenience, jurisdictional access, or a particular off-label use case.

What is the difference between Semax and Dihexa?

Semax is classed as ACTH fragment analog; nootropic; Dihexa is classed as Angiotensin IV analog; HGF potentiator. Reported mechanism: Semax, Upregulates BDNF and NGF; modulates dopamine and serotonin systems; neuroprotective; Dihexa, Enhances HGF/c-Met signaling; promotes synaptogenesis and dendritic spine formation. Reported half-life: Semax, ~5-15 min (intranasal peak); Dihexa, ~10 hrs. Routes in published studies: Semax, Intranasal / SC; Dihexa, Oral / Transdermal.

Which has stronger evidence, Semax or Dihexa?

Semax has the stronger evidence base on PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. Semax is graded Russia-Approved + Anecdotal, with 5 cited sources on its reference page and 150 indexed studies. Dihexa is graded Preclinical + Anecdotal, with 2 cited sources on its reference page and 17 indexed studies.

Which is more accessible, Semax or Dihexa?

Neither Semax nor Dihexa is an FDA-approved drug. Catalog status: Semax, Research / Intl Rx; Dihexa, Research Chemical. Semax's nomination for FDA's bulk-substance lists was flagged by FDA and then withdrawn. Dihexa's nomination for FDA's bulk-substance lists was flagged by FDA and then withdrawn.

Are Semax and Dihexa ever combined?

Semax and Dihexa appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.

Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.

Loading interactive view…